1944P Hyperglycemia increased nivolumab-induced cardiotoxicity, enhanced immunoresistance of ERɑ+, PR+, HER2- breast cancer cells modulating growth factors and NLRP3 expression.

MLA

Quagliariello, V., et al. “1944P Hyperglycemia Increased Nivolumab-Induced Cardiotoxicity, Enhanced Immunoresistance of ERɑ+, PR+, HER2- Breast Cancer Cells Modulating Growth Factors and NLRP3 Expression.” Annals of Oncology, vol. 31, Sept. 2020, p. S1097. EBSCOhost, https://doi.org/10.1016/j.annonc.2020.08.1336.

APA

Quagliariello, V., Bonelli, A., Caronna, A., Lombari, C., Grimaldi, I., Conforti, G., Botti, G., & Maurea, N. (2020). 1944P Hyperglycemia increased nivolumab-induced cardiotoxicity, enhanced immunoresistance of ERɑ+, PR+, HER2- breast cancer cells modulating growth factors and NLRP3 expression. Annals of Oncology, 31, S1097. https://doi.org/10.1016/j.annonc.2020.08.1336

Chicago

Quagliariello, V., A. Bonelli, A. Caronna, C. Lombari, I. Grimaldi, G. Conforti, G. Botti, and N. Maurea. 2020. “1944P Hyperglycemia Increased Nivolumab-Induced Cardiotoxicity, Enhanced Immunoresistance of ERɑ+, PR+, HER2- Breast Cancer Cells Modulating Growth Factors and NLRP3 Expression.” Annals of Oncology 31 (September): S1097. doi:10.1016/j.annonc.2020.08.1336.